Clinical Trial

Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation

Study acronym: T380A
Completed
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine whether immediate postplacental copper T380A intrauterine device insertion increases uterine-niche incidence compared with postpartum progestin-only pills after primary cesarean section .
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-24; most recent amendment 2026-02-25.
Status change: Active, Not Recruiting → Completed 2026-02-25
Trial Details
NCT Number NCT07264933
Lead Sponsor Benha University
Conditions Scar Niche, Myometrial Remodeling, Contraceptive Device; Complications, Cesarean Section Complications
Enrollment 750 participants
Start Date 2025-02-12
Primary Completion 2025-08-05 (estimated)
Study Completion 2026-02-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-27